schedule

Welcome reception 6:30pm to 8pm

Opening remarks/keynote
Dr. Jean-Pierre Boutrand – NAMSA

Concepts in biocompatibility: new biomaterials, new paradigms and new testing regimes
Professor David F. Williams – Wake Forest Institute of Regenerative Medicine

Medical device biocompatibility evaluation: an industry perspective
Dr. Kelly Coleman – Medtronic

Material and chemical characterization for the biological evaluation of medical device biocompatibility
Dr. David Albert – NAMSA

Allowable limits for toxic leachables: practical use of ISO – 10993-17 standard
Dr. Kelly Coleman – Medtronic (London)

Biological safety evaluation planning of biomaterials
David Parente – Ecolab

In vivo and in vitro testing for the biological safety evaluation of biomaterials and medical devices
Dr. Joseph Carraway – NAMSA

Blood compatibility assessment in medical devices: considerations and standards
Michael F. Wolf – Medtronic

Case study: overcoming negative test results during manufacture
David Parente – Ecolab

Methods and interpretation of performance studies for bone implants
Dr. Jean-Pierre Boutrand – NAMSA

Preclinical evaluations and translational research in cardiovascular device development
Dr. Roy Martin – NAMSA

Methods for the characterisation and evaluation of drug-device combination products
Professor Andrew Lewis – Biocompatibles UK Ltd

Biological evaluation and regulation of medical devices in the European Union
Adrian Keene – SGS

Biological evaluation and regulation of medical devices in Japan
Dr. Joseph Carraway – NAMSA

Introduction on Chinese medical device market
An Liu – NAMSA

Biological evaluation and regulation of medical devices in China
Professor Jiao Sun – Shanghai Biomaterials Research & Testing Center, Shanghai Jiaotong University